Loading clinical trials...
Loading clinical trials...
Pulsed Field Ablation (PFA) System for the Treatment of Paroxysmal Atrial Fibrillation (PAF) by Irreversible Electroporation (IRE)
Conditions
Interventions
Pulsed Field Ablation (PFA) Therapy
Locations
13
Austria
Medical University Graz
Graz, Austria
Ordensklinikum Linz Elisabethinen
Linz, Austria
OLV Aalst
Aalst, Belgium
AZ Sint-Jan Brugge
Bruges, Belgium
Ziekenhuis Oost-Limburg Genk Campus Sint-Jan
Genk, Belgium
Jessa Ziekenhuis - Campus Virga Jesse
Hasselt, Belgium
Start Date
August 23, 2020
Primary Completion Date
May 9, 2023
Completion Date
May 9, 2023
Last Updated
May 25, 2025
NCT05147792
NCT06935591
NCT05963698
NCT04947657
NCT03546374
NCT06686485
Lead Sponsor
Biosense Webster, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions